Divergent immunometabolic reprogramming in psoriasis and atopic dermatitis: a tale of two inflammatory skin diseases - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Distinct Immunometabolic Alterations in Psoriasis and Atopic Dermatitis: Insights into Two Inflammatory Skin Conditions

  • By

  • Nan Chen

  • Yehong Yue

  • Liang Zhou

  • July 16, 2026

Share

  • 1

    Psoriasis and atopic dermatitis are the two most common chronic inflammatory skin diseases, with distinct immunological profiles.

  • 2

    Psoriasis is characterized by excessive epidermal proliferation and a Th17-dominant immune response, while AD features impaired skin barrier and a Th2-dominant profile.

  • 3

    Metabolic pathways in immune cells are crucial for cellular differentiation and effector functions, influencing the pathology of both psoriasis and AD.

  • 4

    Psoriasis exhibits upregulated glycolysis and abnormal cholesterol metabolism, whereas AD shows defects in ceramide synthesis and fatty acid metabolism.

  • 5

    The article reviews the therapeutic potential of metabolism-targeted drugs, highlighting differences in treatment approaches for psoriasis and AD.

Original Source(s)

Related Content